Publication | Closed Access
Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoide Artritis
76
Citations
0
References
1998
Year
Combined treatment is cost-effective due to enhanced efficacy at lower or equal direct costs.